Hologic/$HOLX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Hologic
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Ticker
$HOLX
Sector
Primary listing
Employees
7,070
Headquarters
Website
Hologic Metrics
BasicAdvanced
$17bn
31.63
$2.40
0.73
-
Price and volume
Market cap
$17bn
Beta
0.73
52-week high
$76.07
52-week low
$51.90
Average daily volume
6.4m
Financial strength
Current ratio
4.04
Quick ratio
3.1
Long term debt to equity
47.719
Total debt to equity
48.051
Interest coverage (TTM)
9.33%
Profitability
EBITDA (TTM)
1,350.7
Gross margin (TTM)
60.38%
Net profit margin (TTM)
13.18%
Operating margin (TTM)
25.81%
Effective tax rate (TTM)
18.03%
Revenue per employee (TTM)
$580,000
Management effectiveness
Return on assets (TTM)
7.43%
Return on equity (TTM)
10.86%
Valuation
Price to earnings (TTM)
31.628
Price to revenue (TTM)
4.139
Price to book
3.23
Price to tangible book (TTM)
16.11
Price to free cash flow (TTM)
17.842
Free cash flow yield (TTM)
5.60%
Free cash flow per share (TTM)
4.26
Growth
Revenue change (TTM)
2.17%
Earnings per share change (TTM)
-23.84%
3-year revenue growth (CAGR)
-2.60%
10-year revenue growth (CAGR)
4.15%
3-year earnings per share growth (CAGR)
-15.09%
10-year earnings per share growth (CAGR)
14.15%
What the Analysts think about Hologic
Analyst ratings (Buy, Hold, Sell) for Hologic stock.
Hologic Financial Performance
Revenues and expenses
Hologic Earnings Performance
Company profitability
Hologic News
AllArticlesVideos
New Evidence Backs Hologic's AI-Powered Mammography Technology for Detecting Challenging Cancers
Business Wire·2 months ago
Blackstone and TPG Complete Acquisition of Hologic
Business Wire·2 months ago
Hologic Chief Executive Officer Steve MacMillan to Retire Upon Close of Go-Private Transaction
Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs